Liposomal Joint Health Product exoFlex Debuts
March 15, 2017
Product features BiovaFlex, curcumin, boswellia, MSM and vitamin C.
When choosing a natural joint health supplement, it’s not only the ingredients that are important, or even their dosage size, but how the nutrients get to their targeted areas to start providing results. exoFlex is a formulation of potent, synergistic clinically tested nutrients featuring Biova’s BiovaFlex water-soluble egg shell membrane, encapsulated into all-natural lipospheres. These nano-sized liposomes protect the exoFlex ingredients, helping to facilitate a more efficient transition through the enzymes of the digestive system as they make their way into the body's bloodstream.
The body’s joints are basically anatomical structures consisting of two bones, separated by a tough, elastic, shock-absorbing, flexible connective tissue called cartilage. In most cases the cartilage is wrapped in ligaments as well as the tendons of muscles that create the movement at the joints. These articulate joints are found throughout the body providing the ability to move. The number one cause of joint pain is osteoarthritis or age related inflammation, wear and tear and the breakdown of cartilage due to strenuous athletic training or injury on the joint structures. These conditions can create a multitude of symptoms including swelling, pain, irritation and a substantial loss of range of motion coupled with the decreased overall function of the joint.
exoFlex works by providing Biova, LLC’s water-soluble egg membrane BiovaFlex along with select nutraceutical grade nutrients and antioxidants into a liquid oral dosage form. BiovaFlex has demonstrated to reduce joint pain and increase range of motion in clinical studies submitted to Health Canada. This potent formula can assist the body to neutralize and decrease the free radical damage while helping to create the building blocks required to aid in reducing inflammation. exoFlex can also help to promote the rehydration and restoration of essential joint fluids and tissue, thus improving overall joint health and quality of life.
According to Heath Canada exoFlex Product License #80074736
- Starts to help reduce pain at 5 days
- Helps to relieve joint pain associated with osteoarthritis
- Helps to reduce stiffness associated with osteoarthritis
- Helps to relieve pain associated with osteoarthritis of the knee
- Helps to reduce blood C reactive protein levels, a clinical marker of inflammation
- Helps in the development and maintenance of bones
- Helps in the development and maintenance of cartilage
- Helps in connective tissue formation
“We are very excited about the unique system that Aurora & Vida have used to offer BiovaFlex’s benefits to consumers,” said Biova CEO Pat Schneider. “This is a breakthrough in delivery methods and we look forward to how this novel technology will advance joint health for all.”
Phil Bolden, co-president of Vida Lifescience stated, “Our retail partners are very excited about exoFlex. Aurora has applied it’s enhanced liposomal delivery systems to an already clinically demonstrated ingredient (BiovaFlex) and added the benefits of curcumin, boswellia, MSM and vitamin C. exoFlex promises to be a leader in the joint health category. Research shows consumers are seeking new products that deliver results without the side effects of traditional options. “
Aurora Nutrascience’s President - CEO Mr. David J. Johnson commented, “working with Biova and their professional team has been instrumental in the utilization of their BiovaFlex™ nutrient in creation of a product that our competition simply could not fathom. exoFlex™ is a result of the extensive evaluation and development by our lab technicians and represents a very unique and innovative product that offers several improvements over other offerings in the Joint Support & Mobility sector of the market today. In our opinion exoFlex™ is the smarter, scientifically created, all-natural, drug-free solution for people with joint related stress, inflammation, osteoarthritis, tendinitis or other degenerative issues.”